BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20954830)

  • 1. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.
    You BR; Park WH
    Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2009 Nov; 24(5):717-22. PubMed ID: 19787207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    Han YH; Park WH
    Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
    Park WH
    Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MG132, a proteasome inhibitor, induced death of calf pulmonary artery endothelial cells via caspase-dependent apoptosis and GSH depletion.
    Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2010 Mar; 30(3):879-85. PubMed ID: 20393010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
    Han YH; Moon HJ; You BR; Park WH
    Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
    Han YH; Park WH
    Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death.
    Han YH; Park WH
    Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propyl gallate inhibits the growth of endothelial cells, especially calf pulmonary arterial endothelial cells via caspase-independent apoptosis.
    Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Jun; 25(6):937-44. PubMed ID: 20428799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antimycin A on endothelial cells in cell death, reactive oxygen species and GSH levels.
    You BR; Park WH
    Toxicol In Vitro; 2010 Jun; 24(4):1111-8. PubMed ID: 20332020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    Park WH; Kim SH
    Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrogallol-induced calf pulmonary arterial endothelial cell death via caspase-dependent apoptosis and GSH depletion.
    Han YH; Park WH
    Food Chem Toxicol; 2010 Feb; 48(2):558-63. PubMed ID: 19913593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
    Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 inhibitor enhances growth inhibition and death in gallic acid-treated endothelial cells.
    Yang YM; Park WH
    Int J Mol Med; 2010 Aug; 26(2):295-300. PubMed ID: 20596611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propyl gallate inhibits the growth of calf pulmonary arterial endothelial cells via glutathione depletion.
    Han YH; Moon HJ; You BR; Park WH
    Toxicol In Vitro; 2010 Jun; 24(4):1183-9. PubMed ID: 20159035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of propyl gallate-induced calf pulmonary arterial endothelial cell death by MEK and JNK inhibitors.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Med Rep; 2009; 2(5):825-30. PubMed ID: 21475908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.